


Journal Home
Contents
Editorial Board
Instructions for Contributors
Subscription Rates
© Neva Press, Inc. 2005 |
|
CNS Drug Reviews
Table of Contents
Volume 11, No. 3
Reviews
|
229 |
|
Cotinine, a Neuroactive Metabolite of Nicotine: Potential
for Treating Disorders of Impaired Cognition
Alvin V. Terry, Jr., Caterina M. Hernandez, Elizabeth J.
Hohnadel,
Kristy P. Bouchard, and Jerry J. Buccafusco
[Abstract]
[Article]
[Single Reprint] |
253 |
|
Ropinirole, a Non-Ergoline Dopamine Agonist
Wolfgang H. Jost and Dieter Angersbach
[Abstract]
[Article]
[Single Reprint] |
273 |
|
Pharmacological Properties, Central Nervous System Effects, and
Potential Therapeutic Applications of Atipamezole, a Selective
α2-Adrenoceptor
Antagonist
Antti Pertovaara, Antti Haapalinna, Jouni Sirviö and Raimo
Virtanen
[Abstract]
[Article]
[Single Reprint] |
289 |
|
Preclinical Neuropharmacology of Naratriptan
Geoffrey A. Lambert
[Abstract]
[Article]
[Single Reprint]
|
317 |
|
Clinical Potential of GABAB Receptor Modulators
Jennifer Ong and David I. B. Kerr
[Abstract]
[Article]
[Single Reprint]
|
MEETING REPORTS |
335 |
|
Alzheimer’s Association International Conference on Prevention of
Dementia. Washington, D.C. June 18–21, 2005.
Alexander Scriabine
[Article]
[Single Reprint]
|
339 |
|
IBC’s 10th Annual World Congress. Drug Discovery Technology
and Development 2005. Boston, MA. August 8–11, 2005.
Alexander Scriabine
[Article]
[Single Reprint] |
|
|
|